Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Shurell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The American Surgeon|March 12, 2015
A single-center experience and review of the literature: 64 cases of phyllodes tumors to better understand risk factors and disease managementAmy L Lightner, Elizabeth Shurell, Nicole Dawson, et al.
Surgical Oncology Clinics of North America|September 4, 2016
Malignant Peripheral Nerve Sheath TumorAaron W James, Elizabeth Shurell, Arun Singh, et al.
Cancer|September 30, 2017
Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situElizabeth Shurell, Cristina Olcese, Sujata Patil, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
Nonpharmacological amelioration of age-related learning deficits: the impact of hippocampal theta-triggered trainingYukiko Asaka, Kristin N Mauldin, Amy L Griffin, et al.
Plos One|August 9, 2016
Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse ModelMako Yamamoto, Ming Zhao, Yukihiko Hiroshima, et al.
Oncotarget|September 23, 2016
Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcomaElizabeth Shurell, Maria E Vergara-Lluri, Yunfeng Li, et al.
Oncotarget|September 3, 2016
Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytesElizabeth Shurell, Arun S Singh, Joseph G Crompton, et al.
BMC Cancer|November 16, 2014
Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patientsElizabeth Shurell, Linh M Tran, Jonathan Nakashima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data setsAlessandro Gronchi, Rosalba Miceli, Elizabeth Shurell, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The American Surgeon|March 12, 2015
A single-center experience and review of the literature: 64 cases of phyllodes tumors to better understand risk factors and disease managementAmy L Lightner, Elizabeth Shurell, Nicole Dawson, et al.
Surgical Oncology Clinics of North America|September 4, 2016
Malignant Peripheral Nerve Sheath TumorAaron W James, Elizabeth Shurell, Arun Singh, et al.
Cancer|September 30, 2017
Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situElizabeth Shurell, Cristina Olcese, Sujata Patil, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
Nonpharmacological amelioration of age-related learning deficits: the impact of hippocampal theta-triggered trainingYukiko Asaka, Kristin N Mauldin, Amy L Griffin, et al.
Plos One|August 9, 2016
Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse ModelMako Yamamoto, Ming Zhao, Yukihiko Hiroshima, et al.
Oncotarget|September 23, 2016
Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcomaElizabeth Shurell, Maria E Vergara-Lluri, Yunfeng Li, et al.
Oncotarget|September 3, 2016
Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytesElizabeth Shurell, Arun S Singh, Joseph G Crompton, et al.
BMC Cancer|November 16, 2014
Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patientsElizabeth Shurell, Linh M Tran, Jonathan Nakashima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data setsAlessandro Gronchi, Rosalba Miceli, Elizabeth Shurell, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Pageof 1